Exercise Cuts Colon Cancer Recurrence Risk by 28% and Deaths by 37%—Landmark CHALLENGE Trial Shows
The CHALLENGE trial, a landmark phase 3 randomized controlled study published in the New England Journal of Medicine in 2025, has provided the strongest evidence yet that regular moderate exercise can dramatically lower the risk of colon cancer recurrence and improve survival rates in survivors—effects comparable to some adjuvant therapies. Key Findings from the Groundbreaking […]














